chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning an approximate 70-year-old female who in approximately February 2008, was vaccinated with a dose of Zostavax (Oka/Merck). In approximately February 2008, it was reported the patient was on vacation and experienced a rash 10 days after vaccination and called the doctors office to let them known about it. The rash was over her entire body and the patient was going to follow-up with a doctor where she was vacationing. At the time of the report the patient's status was unknown. Additional information has been requested. 06/24/2008 This is in follow-up to report(s) previously submitted on 3/26/2008. Information has been received from a registered nurse concerning an 80 year-old female with no known allergies who on 30-OCT-2007, was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot # 658602/1080U). Concomitant therapy included an unspecified influenza vaccine "within the last 4 weeks". On 07-NOV-2007, the patient was on vacation and broke out in a rash on 04-NOV-2007 (also reported as 10 days after vaccination) and called the doctors office to let them know about it. The rash was over her entire body but especially on her face and arms. The patient stated that "it looks like chicken pox before it blisters to heads" and "I have shingles". She did not complain of pain or itching. She stated that she felt fine. The patient was going to follow-up with a doctor where she was vacationing the next day. At the time of the report the patient's status was unknown. In follow up the registered nurse indicated that they were unable to follow up with the patient because she did not answer her telephone on vacation for the next 3 days and her other telephone number was disconnected. Additional information is not expected.
Severe Myalgias x24 hrs Fever to 102F x72 hours Fatigue/Weakness/Brain Fog/Malaise/Cognitive Dysfunction for greater than one week, ongoing
2 minutes after administration of vaccine, patient reported feeling dizzy, having blurred vision, and right arm pain. Respirations were WNL and patient was placed in reclined position. After an additional 5 minutes (15:12), patient requested to stand up and sit in waiting area. Patient began to feel faint as she walked to the waiting area and needed to be lowered to the ground.  At 15:20, mother gave approval for patient to receive 0.3 ml of epinephrine IM after patient reported severe pain in right, swelling and tingling in tongue and was observed to have muscle contraction in all extremities. 911 was called and arrived at 15:25. Patient taken to nearby hospital for further assessment.
received the diluent portion only; received the diluent portion only; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number DE9LR, expiry date 27th January 2023) for prophylaxis.   On 26th August 2021, the patient received the 1st dose of Shingrix. On 26th August 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that, the patient received the diluent portion only of Shingrix without being reconstituted with the powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not consent to follow up.
fever, body aches, headache, and vomiting began 11/15/23, day after vaccine with no symptoms before vaccine.  I, her mother and a family nurse practitioner had similar symptoms but not the vomiting after my own Moderna booster
fever; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Pain, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided  by the reporter.
Administered influenza injection on 12/15/2009 and another influenza injection given on 12/17/09. No adverse reactions noted at this time. Flulaval vaccination given to resident twice.
sick; blood in his urine; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (sick) and BLOOD URINE PRESENT (blood in his urine) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced ILLNESS (sick) and BLOOD URINE PRESENT (blood in his urine). At the time of the report, ILLNESS (sick) and BLOOD URINE PRESENT (blood in his urine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Culture urine: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Patient was given a prescription for antibiotics based on the assumption that culture will come back positive for UTI.
Bloody nose; Randomly began bleeding vaginally, although it is not that time of the month.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 13May2021 at 20:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic scleroderma. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received no past drug or medication. On 15May2021 at 09:00, the patient randomly began bleeding vaginally, although it was not that time of the month and this evening the patient got a bloody nose. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the events randomly began bleeding vaginally, although it was not that time of the month and bloody nose were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient stated that starting about 2 hours after receiving the vaccine he had the following symptoms: Fever (99.6), Increased heart rate (122 bpm) lowered BP (systolic was 100 when he usually runs 140); he also had a rash at site of injection and swelling along his Right Axilla and up into his neck/down right side of torso.
AFTER RECEIVING THE FLU SHOT THE PATIENT PRESENTED WITH RASH IN BOTH ARMS IN THE BICEPS AREA.
Patient received vaccine and started to feel lightheaded and flushed about 5 minutes after the dose. She fainted and was assisted to the ground. She did not lose consciousness. She was asked about her recent insulin dose and it was suspected that she did not eat enough food after taking her morning insulin.
PATIENT PRESENTED AT OFFICE WITH C/O FEVER OF 102.7 ONSET OF 04\03\2007
Patient came in for an appointment and to receive his first dose of the Pfizer 12+ teen covid vaccine. An MA mistakenly administered a 5-11yrs old pfizer covid vaccine instead. Patient received this vaccine at 12pm. Patient and mom then walked over to the observation area by the MA so this RN could observe. RN observed patient for 30 minutes; patient had no side effects/reaction and upon visual observation was in no distress. The MA notified provider and manager regarding medication error. RN then notified mom of medication error. Mom verbalized understanding.
This case was reported by a nurse via sales rep and described the occurrence of injection site burning in an unspecified number of patients who received FLUARIX TETRA. On an unknown date, the patients received FLUARIX TETRA at an unknown dose. On an unknown date, less than a month after receiving FLUARIX TETRA, the patients experienced injection site burning, injection site itching, injection site redness, injection site swelling and injection site warmth. On an unknown date, the outcome of the injection site burning, injection site itching, injection site redness, injection site swelling and injection site warmth were unknown. The reporter considered the injection site burning, injection site itching, injection site redness, injection site swelling and injection site warmth to be related to FLUARIX TETRA. Additional details were provided as follows: The age at vaccination for the patients was not reported. The reporter had noticed high percentage of patients who had received the FLUARIX QUADRIVALENT vaccine via the prefilled syringes for the 2016-2017 season and had experienced local injection site reactions including itching, burning, redness, swelling and hot feeling. Other patients had experienced only burning as the vaccine was being administered (refer case US2016GSK136583). The field representative was unable to provide any further details at the time of the call. The field representative indicated that this practice was a new user of the FLUARIX QUADRIVALENT product and had only been using the product for approximately two weeks before the time of reporting. He was also going to contact Medical Information.
Arm is hard to the touch; Arm is red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is hard to the touch) and ERYTHEMA (Arm is red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is hard to the touch) and ERYTHEMA (Arm is red). At the time of the report, PAIN IN EXTREMITY (Arm is hard to the touch) and ERYTHEMA (Arm is red) outcome was unknown.            No concomitant medications were provided by reporter. No treatment medications were reported.  The patient queried upon follow up about what were the side effects of the 50 mcg booster dose, and whether they were the same as experienced after receiving the primary series or different than that.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jan-2022: Follow-up information received contains non significant information
Tingles in right calf progressed over the course of a couple weeks  to all over body paresthesias.  6 days post vaccine experienced upper and lower backaches and headaches which continued for approximately 3-4 weeks on and off.  Approximately 2/3 weeks post vaccination numbness in couple of digits of fingers and toes occurred on and off but subsided after  24 hours.   Paresthesias (tingling) all over body still occur currently to this date however seem to be less frequent.  Paresthesias subsided while lying down or sleeping.
Patient came in to clinic with mom, requesting a flu vaccine.  Patient received but only after administration did this writer noticed that the dose of flu  mist vaccine was expired.  Date of expiration on Jan 13, 2022. No reported symptoms or adverse effects.
101.2 FEVER,  Tylenol taken, fever was gone in about 24 hours
Reported fever 101, myalgias, nausea on May 25, 2013; symptoms self resolved on f/u phone contact 05/28/2013.
c/o body aches, h/a on & off x 9 days; diarrhea x 4-5 days now gone; flu like sx relieved w/APAP which has been taking regularily over the last 9 days to alleviate sx;
Patient developed hives on their chest and bilateral arms and difficulty breathing with concerns for anaphylaxis. On examination in the ED, the patient was noted to have a urticarial rash, mild oropharyngeal swelling and erythema, inspiratory stridor. Patient was initiated on anaphylaxis therapy after RRT on arrival to resuscitation room, starting with 0.3 mg of IM epinephrine. Also provided 50 mg of Benadryl, 20 mg famotidine, 125 mg of Solu-Medrol. Lactated Ringer's infusion began, received 1L LR. Patient was discharged home after resolution of symptoms.
Palm sized sore to touch just at the location of the shot.; Pregnant at the time of vaccination?: Yes/ Last menstrual period date 31Oct2020; This is a spontaneous report from a contactable consumer. A 32-years-old pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER2613), via an unspecified route of administration, in left arm on 12Apr2021 at 14:45 (at the age of 32-years-old) as a single dose for COVID-19 immunization. The patient medical history included periodontal disease. The concomitant medication of the patient was not reported. The patient had no allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19 and patient does not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient was not tested for COVID-19. On 12Apr2021 patient was pregnant at the time of vaccination and last menstrual period date of patient was 31Oct2020 with gestation period of 23 weeks. The delivery date of the patient was reported as 07Aug2021. On 13Apr2021 at 07:00 the patient experienced palm sized sore to touch just at the location of the shot which occurred next day and lasted one day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Outcome of the reported event of palm sized sore to touch just at the location of the shot was recovered on unspecified date of Apr2021.  No follow-up attempts are possible. No further information is expected.
Received DTAP and HIB/Hep B 9/17/02 pm.  By 9pm child's rectal temp was over 102(child was too irritable to leave thermometer in long enough for accurate temp)after receiving Tylenol at 7pm.  Child very irritable, crying, difficult to console.  Mom states child was somewhat irritable and had fever for several hours after first DTAP.  No redness or swelling at the sites of injections.
10 minutes after receiving 2nd dose of moderna covid Vaccine patient complained about itching and burning at and near site of injection.  Her arm was red from scratching. Patient denied any reaction for first dose of vaccine. Patient denied and SOB or swelling around eyes nose or mouth. Patient denied and itching in mouth or throat or any other site besides site of injection. Patient was offered benadryl for local itching  but denied any. Patient was advised to stay close to pharmacy for further observation for 40 more minutes. After 15 minutes of the reaction patient said itching and burning was subsiding and felt no other signs or symptoms of itching or allergic reaction. Patient was advised if any other side effect including what to look out for in regards to severe side effects and what to do in the event of those side effects.
Chills.  Aching muscles and joints.   Tired and weak.  Lasted 36 hours.   Slept 13 hours and treated with ibuprofen.
This resident is a new resident to the facility, admitted on 03/09/2021 according to the patient chat.  Staff member are not aware the patient already received 2 doses of Pfizer ( on 01/19 and 02/09) at the facility she previously lived in.  Staff filled out the consent and answered "No" to the question she has ever received COVID vaccine.  I have no way of knowing or verifying with the patient because she is nonverbal.  So, I gave her a dose of Moderna. I only found out after getting an insurance reject and looked up immunization registry.
I had first shot of SHINGRIX at 9am. Took 2 ADVIL immediately. Felt perfectly healthy all day. 7pm I became extremely sick within half hour. Very high fever (no thermometer), chills, shivering, possible all over muscles spasms (or I couldn't stop moving because I was so cold nothing worked to warm me up). Fever finally broke 11pm. Then night sweats all night. Next day fever 100.4 went to doctor to make certain it wasn't flu (had flu shot October). Definitely not flu. No explanation given other than SHINGRIX side effects . Today, slight fever 99.0. I have never been so sick in my life, Ever. Vaccine from pharmacy. Side notes... I have had Plantar Fasciitis for 1 months. I woke up the next morning and it was gone. Secondary benefits or coincidence?
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 3:49 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 3:49 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 69.59.  No concomitant medications were reported.  On 27-Oct-2021 at 09:00 A.M., the temperature recorded was 29 degree Fahrenheit and vial was initially moved to the fridge on 29-Sep-2021 and beyond use date was 29-Oct-2021. Product moved to clinic on 27-Oct-2021, and at 10:00 Am the temperature recorded was 32 degree Fahrenheit and vial was initially moved to the fridge on 05-Oct-2021 and beyond use date was 04-Nov-2021. Product moved to clinic on 27-Oct-2021.  Vial was stored on cooler 1, on 27-Oct-2021, Excursion duration At 9 AM: 29, 10 AM: 32.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Injection on 1/27-- On 1/28 chills, no temp, pain in left arm including injection site, underarm and left chest, extreme fatigue and though intake was limited excessive urination was noted. 2/11 heart noted to be above 120 at home to ER where heart rate was over 110.Shortness of air with increased heart rate.  2/15 Resting heart rate remained elevated and left side chest and arm pain.
This was a booster.  I had Johnson and Johnson for primary course on 3/31/21. Symptoms of nausea, headache, fever, pain began about 4-6 hours after the injection and became worse over the next 12 hours. Fever waned around 24 hours, with pain and nausea continuing. Diarrhea began around 30 hours and has not resolved.
I woke up the next morning with a half dollar red patch at the injection site, and a lump the size of a ping pong ball and Sunday I made the call to the pharmacy and went to urgent care it was a little bit bigger.
Tingling sensation around the mouth area 2 days prior, eruption of blisters under the nose on the 3rd day, similar to cold sores. Patient did not have prior episodes of cold sores.
29Aug89 pt vax w/ hepta B; over next 2 weeks exp vision difficulty as if looking through gas vapors, h/a, nausea.  16Sep89 lost vision in left eye.  Dx as macular edema + retinal pigment epithelialitis.
Headache, fever and fatigue. As for treatment Tylenol was used every 4 hours. Feeling better, headache is gone but still feel fatigue and the temperature seems to be under control.
Pt was administered a vaccine that had expired 2 days prior on (02.28.2021) - per pt's MD, she does not feel as though pt is at risk by recieving this vaccine 2 days past expiration or feel as though pt needs to be revaccinated.
Several hours after the shot I started getting a numb feeling in my feet.  the next morning there was a 'rushing' feeling flowing through my legs. About a week or so later I began experiencing numbness in my hands as well.  At times I would also experience numbness on my face as well.    As the weeks went on, the numbness in the legs and hands continued and got more intense.  At times I have had difficulty sleeping due to the numbness I experience and on occasion, my hands a feet had a 'pins and needles' painful feeling about them which made it difficult to sleep.  Prior to this shot I was a normal 39 year old with absolutely no pre-existing  neurology issues.